Cour Pharmaceuticals Development Co Inc — Form D
Cour Pharmaceuticals Development Co Inc of Northbrook, IL, a company, filed a Form D exempt-offering notice with the SEC on 2014-08-28. The offering totals $500K, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-08-28
- Form: D
- Accession: 0001568153-14-000001
- Industry: Biotechnology
- Exemptions: 04
- Total offering: $500K
- Amount sold: $500K
- Minimum investment: $500K
- Investors: 1
- Date of first sale: 2014-08-25
- Security types: debt
- Revenue range: $1 - $1,000,000
- SEC file number: 021-223780
Issuer
- Name: Cour Pharmaceuticals Development Co Inc
- CIK: 0001568153
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 2215 Sanders Road, Suite 425, Northbrook, IL, 60062
- Phone: 630-833-3254
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Daniel Getts | Director | Washington, DC |
| John Puisis | Director | Kalamazoo, MI |
| John Puisis | Executive Officer | Kalamazoo, MI |
| Catherine J Mackey | Director | San Diego, CA |
| John J Puisis | Director | Northbrook, IL |
| John J Puisis | Executive Officer | Northbrook, IL |
| James J Herrmann | Director | Northbrook, IL |
| James J Herrmann | Executive Officer | Northbrook, IL |
| Daniel Getts | Executive Officer | Washington, DC |
| James Herrmann | Executive Officer | Kalamazoo, MI |
Other filings by this issuer (3)
More